BGR GOVERNMENT AFFAIRS

Lobbying for PTC THERAPEUTICS · Biopharmaceutical

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Provide guidance and advocacy with regard to regulations and legislation that could impact the pharmaceutical industry generally, and PTC specifically.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.